LLY - Lilly's Retevmo gains approval for children as young as two with thyroid cancer
2024-05-29 12:32:44 ET
More on Eli Lilly
- Eli Lilly: Addressing Supply Challenges Should Accelerate Growth
- Eli Lilly: Great Time To Divest Before It Potentially Crashes
- Eli Lilly Remains Expensive Here - Minimal Margin Of Safety
- Ro provides supply tracking feature for Lilly, Novo Nordisk weight loss drugs
- SA Asks: Who will launch the next big weight-loss drug?